DeviceClearance

Product code SEE— Neurology

CT-132

Classification name
Computerized Behavioral Therapy Device For Migraine
Device class
Class 2
Regulation
21 CFR 882.5806
Advisory panel
Neurology
Total cleared
1
First cleared
Most recent

FDA classification definition

“A computerized behavioral therapy device for headache is a prescription device intended to provide a computerized version of behavioral therapy for the treatment of headache.”

— U.S. Food and Drug Administration, device classification record for product code SEE under 21 CFR 882.5806, via openFDA

Market context for product code SEE

FDA has cleared 1 device under product code SEE, all in 2025, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code SEE

Recent clearances under product code SEE

Data sourced from openFDA. This site is unofficial and independent of the FDA.